A novel Galleria mellonella experimental model for zoonotic pathogen Brucella

References

• Pappas G, et al. Brucellosis. N Engl J Med. 2005;352(22):2325–16. doi: 10.1056/NEJMra050570
   PubMed Web of Science ®Google Scholar
• Dean AS, Crump L Greter H, et al., Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012;6(10): e1865.
   PubMed Web of Science ®Google Scholar
• Franco MP, Mulder M, Gilman RH, et al. Human brucellosis. Lancet Infect Dis. 2007;7(12):775–786. doi: 10.1016/S1473-3099(07)70286-4
   PubMed Web of Science ®Google Scholar
• Boschiroli ML, Foulongne V, O’Callaghan D. Brucellosis: a worldwide zoonosis. Curr Opin Microbiol. 2001;4(1):58–64. doi: 10.1016/S1369-5274(00)00165-X
   PubMed Web of Science ®Google Scholar
• Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91–99. doi: 10.1016/S1473-3099(06)70382-6
   PubMed Web of Science ®Google Scholar
• Lalsiamthara J, Lee JH. Development and trial of vaccines against Brucella. J Vet Sci. 2017;18(S1):281–290. doi: 10.4142/jvs.2017.18.S1.281
   PubMedGoogle Scholar
• Cheng Z, Li Z, Yin Y, et al. Characteristics of Brucella abortus vaccine strain A19 reveals its potential mechanism of attenuated virulence. Vet Microbiol. 2021;254:109007. doi: 10.1016/j.vetmic.2021.109007
   PubMed Web of Science ®Google Scholar
• Dorneles EM, Sriranganathan N, Lage AP. Recent advances in Brucella abortus vaccines. Vet Res. 2015;46(1):76. doi: 10.1186/s13567-015-0199-7
   PubMed Web of Science ®Google Scholar
• Heidary M, Dashtbin S, Ghanavati R, et al. Evaluation of brucellosis vaccines: a comprehensive review. Front Vet Sci. 2022;9:925773. doi: 10.3389/fvets.2022.925773
   PubMed Web of Science ®Google Scholar
• Hou H, Liu X, Peng Q. The advances in brucellosis vaccines. Vaccine. 2019;37(30):3981–3988. doi: 10.1016/j.vaccine.2019.05.084
   PubMed Web of Science ®Google Scholar
• Yang X, Skyberg JA, Cao L, et al. Progress in Brucella vaccine development. Front Biol (Beijing). 2013;8(1):60–77. doi: 10.1007/s11515-012-1196-0
   PubMedGoogle Scholar
• Schurig GG, Sriranganathan N, Corbel MJ. Brucellosis vaccines: past, present and future. Vet Microbiol. 2002;90(1–4):479–496. doi: 10.1016/S0378-1135(02)00255-9
   PubMed Web of Science ®Google Scholar
• Yu D, Hui Y, Zai X, et al. Comparative genomic analysis of Brucella abortus vaccine strain 104M reveals a set of candidate genes associated with its virulence attenuation. Virulence. 2015;6(8):745–754. doi: 10.1080/21505594.2015.1038015
   PubMed Web of Science ®Google Scholar
• Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, et al. The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle. Infect Immun. 2009;77(2):877–884. doi: 10.1128/IAI.01017-08
   PubMed Web of Science ®Google Scholar
• Spink WW, HALL JW, FINSTAD J, et al. Immunization with viable Brucella organisms. Results of a safety test in humans. Bull World Health Organ. 1962;26(3):409–419.
   PubMed Web of Science ®Google Scholar
• Ashford DA, di Pietra J, Lingappa J, et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine. 2004;22(25–26):3435–3439. doi: 10.1016/j.vaccine.2004.02.041
   PubMed Web of Science ®Google Scholar
• López-Goñi I, García-Yoldi D, Marín CM, et al. Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all Brucella species, including the vaccine strains. J Clin Microbiol. 2008;46(10):3484–3487. doi: 10.1128/JCM.00837-08
   PubMed Web of Science ®Google Scholar
• Bardenstein S, Mandelboim M, Ficht TA, et al. Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene. J Clin Microbiol. 2002;40(4):1475–1480C. doi: 10.1128/JCM.40.2.1475-1480.2002
   PubMed Web of Science ®Google Scholar
• Blasco JM, Díaz R. Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet. 1993;342(8874):805. doi: 10.1016/0140-6736(93)91571-3
   PubMed Web of Science ®Google Scholar
• Xin X. Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine. Vaccine. 1986;4(4):212–216. doi: 10.1016/0264-410X(86)90131-3
   PubMed Web of Science ®Google Scholar
• Mustafa AA, Abusowa M. Field-oriented trial of the Chinese Brucella suis strain 2 vaccine on sheep and goats in Libya. Vet Res. 1993;24(5):422–429.
   PubMed Web of Science ®Google Scholar
• Silva TM, Costa EA, Paixão TA, et al. Laboratory animal models for brucellosis research. J Biomed Biotechnol. 2011;2011:518323. doi: 10.1155/2011/518323
   PubMed Web of Science ®Google Scholar
• Grilló MJ, Blasco JM, Gorvel JP, et al. What have we learned from brucellosis in the mouse model? Vet Res. Vet Res. 2012;43(1):29. doi: 10.1186/1297-9716-43-29
   PubMedGoogle Scholar
• Tsai CJ, Loh JM, Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence. 2016;7(3):214–229C. doi: 10.1080/21505594.2015.1135289
   PubMed Web of Science ®Google Scholar
• Sheehan G, Garvey A, Croke M, et al. Innate humoral immune defences in mammals and insects: the same, with differences ? Virulence. 2018;9(1):1625–1639. doi: 10.1080/21505594.2018.1526531
   PubMed Web of Science ®Google Scholar
• Cutuli MA, Petronio Petronio G, Vergalito F, et al. Galleria mellonella as a consolidated in vivo model hosts: new developments in antibacterial strategies and novel drug testing. Virulence. 2019;10(1):527–541. doi: 10.1080/21505594.2019.1621649
   PubMed Web of Science ®Google Scholar
• Champion OL, Wagley S, Titball RW. Galleria mellonella as a model host for microbiological and toxin research. Virulence. 2016;7(7):840–845. doi: 10.1080/21505594.2016.1203486
   PubMed Web of Science ®Google Scholar
• Desbois AP, Coote PJ. Utility of greater wax moth larva (Galleria mellonella) for evaluating the toxicity and efficacy of New antimicrobial agents. Adv Appl Microbiol. 2012;78:25–53.
   PubMed Web of Science ®Google Scholar
• Tsai CJ, Loh JMS, Proft T. The use of Galleria mellonella (wax moth) as an infection model for group a streptococcus. Methods Mol Biol. 2020;2136:279–286.
   PubMedGoogle Scholar
• Dijokaite A, Humbert MV, Borkowski E, et al. Establishing an invertebrate Galleria mellonella greater wax moth larval model of Neisseria gonorrhoeae infection. Virulence. 2021;12(1):1900–1920. doi: 10.1080/21505594.2021.1950269
   PubMed Web of Science ®Google Scholar
• Yang Q, Zai X, Yin Y, et al. Construction and immunoprotective evaluation of Brucella 104M: Omp19 overexpression mutant strain. Lett Biotechnol. 2018;29(1):6.
   Google Scholar
• Kwon H, Smith RC. Chemical depletion of phagocytic immune cells in Anopheles gambiae reveals dual roles of mosquito hemocytes in anti-Plasmodium immunity. Proc Natl Acad Sci USA. 2019 Jul 9;116(28):14119–14128.
   PubMed Web of Science ®Google Scholar
• Yang J, He C, Zhang H et al. Evaluation and differential diagnosis of a genetic marked Brucella vaccine A19ΔvirB12 for cattle. Front Immunol. 2021;12:679560. doi: 10.3389/fimmu.2021.679560
   PubMed Web of Science ®Google Scholar
• Zai X, Yin Y, Guo F, et al. Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology. Vet Res. 2021;52(1):75. doi: 10.1186/s13567-021-00939-5
   PubMed Web of Science ®Google Scholar
• Pasquevich KA, Carabajal MV, Guaimas FF, et al. Omp19 enables Brucella abortus to evade the antimicrobial activity from host’s proteolytic defense System. Front Immunol. 2019;10:1436. doi: 10.3389/fimmu.2019.01436
   PubMed Web of Science ®Google Scholar
• Uslu A, Erganis O. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model. Mol Immunol. 2021;133:44–52C. doi: 10.1016/j.molimm.2021.02.006
   PubMed Web of Science ®Google Scholar
• Wang X, Li Z, Li B, et al. Bioluminescence imaging of colonization and clearance dynamics of Brucella suis vaccine strain S2 in mice and Guinea pigs. Mol Imaging Biol. 2016;18(4):519–526. doi: 10.1007/s11307-015-0925-6
   PubMed Web of Science ®Google Scholar
• Bosseray N, Plommet M. Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice. Vaccine. 1990;8(5):462–468. doi: 10.1016/0264-410X(90)90247-J
   PubMed Web of Science ®Google Scholar
• Zhu L, Feng Y, Zhang G, et al. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections. Vaccine. 2016;34(3):395–400. doi: 10.1016/j.vaccine.2015.09.116
   PubMed Web of Science ®Google Scholar
• Antoran A, Aparicio-Fernandez L, Pellon A, et al. The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo. Sci Rep. 2020;10(1):9206. doi: 10.1038/s41598-020-65859-4
   PubMed Web of Science ®Google Scholar
• Fregonezi NF, Oliveira LT, Singulani JD, et al. Heat shock protein 60, insights to its importance in Histoplasma capsulatum: from biofilm formation to host-interaction. Front Cell Infect Microbiol. 2020;10:591950. doi: 10.3389/fcimb.2020.591950
   PubMed Web of Science ®Google Scholar
• Wei C, Yang WH, Hou XX, et al. Immunization efficacy and safety of Brucella 104M against aerosol challenge in BALB/c mice. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(7):1103–1109. doi: 10.3760/cma.j.cn112338-20190911-00665
   PubMedGoogle Scholar
• Sprynski N, Valade E, Neulat-Ripoll F. Galleria mellonella as an infection model for select agents. Methods Mol Biol. 2014;1197:3–9.
   PubMedGoogle Scholar
• Torres M, Pinzón EN, Rey FM, et al. Galleria mellonella as a novelty in vivo model of host-pathogen interaction for malassezia furfur CBS 1878 and malassezia pachydermatis CBS 1879. Front Cell Infect Microbiol. 2020;10:199. doi: 10.3389/fcimb.2020.00199
   PubMed Web of Science ®Google Scholar
• Hernando-Ortiz A, Mateo E, Perez-Rodriguez A, et al. Virulence of candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models. Virulence. 2021;12(1):1063–1075. doi: 10.1080/21505594.2021.1908765
   PubMed Web of Science ®Google Scholar
• Elizalde-Bielsa A, Aragón-Aranda B, Loperena-Barber M, et al. Development and evaluation of the Galleria mellonella (greater wax moth) infection model to study Brucella host-pathogen interaction. Microb Pathog. 2023;174:105930. doi: 10.1016/j.micpath.2022.105930
   PubMed Web of Science ®Google Scholar